ADAMTS13 and thrombotic thrombocytopenic purpura: The majority of these samples were confirmed to contain anti-ADAMTS13 IgG autoantibodies, with 43 out of 44 TTP samples having anti-ADAMTS13 autoantibody signal levels that are twofold higher than healthy control (HC) average levels, which were considered as the background (Figure 3A, F).